Anthony Kim, MD, MS

Medical director of the UCSF Stroke Center

Dr. Anthony S. Kim is a vascular neurologist and medical director of the UCSF Stroke Center. He specializes in stroke prevention, management of transient ischemic attack and stroke, and management of cerebral aneurysms. Kim primarily cares for patients in the hospital, including the Neurointensive Care Unit. He also provides follow-up care, initial consultations and second opinions for patients with complex neurovascular disorders in the UCSF Neurovascular Disease and Stroke Center. Conditions he treats include stroke, arteriovenous and cavernous malformations, carotid stenosis, and intracerebral and subarachnoid hemorrhage.

In his research, Kim's interests include stroke epidemiology, prevention and diagnosis; acute management of stroke; and the use of information technologies to improve the quality of health care. Kim earned an undergraduate degree at Brown University and a medical degree at UCSF, where he completed a neurology residency and served as co-chief resident. He completed a fellowship in vascular neurology and earned a master's degree in clinical research at UCSF. He is a member of the American Academy of Neurology, American Heart Association, and American Stroke Association. Kim is an associate professor of Neurology at UCSF.


Neurovascular Disease and Stroke Center
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-8897
Fax: (415) 353-8705

Hours: Monday to Friday
8:30 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Vascular Neurology

More about Anthony Kim


UCSF School of Medicine 2002


UCSF Medical Center, Neurology 2006


UCSF Medical Center, Vascular Neurology 2009

Selected Research and Publications

  1. Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, Gerstenhaber B, Guarino PD, Dixit A, Furie KL, Kernan WN. Smoking cessation and outcome after ischemic stroke or TIA. Neurology. 2017 Oct 17; 89(16):1723-1729.
  2. Guterman EL, Kim AS, Josephson SA. Neurologic consultation and use of therapeutic hypothermia for cardiac arrest. Resuscitation. 2017 Sep; 118:43-48.
  3. Amarenco P, Kim AS. Aspirin's Benefits Were Previously Underestimated and Are Primarily Accrued in the Acute Setting. Stroke. 2017 May; 48(5):1438-1440.
  4. Chow FC, Price RW, Hsue PY, Kim AS. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals. J Stroke Cerebrovasc Dis. 2017 May; 26(5):1154-1160.
  5. Feldman WB, Kim AS, Chiong W. Trends in Recruitment Rates for Acute Stroke Trials, 1990-2014. Stroke. 2017 Mar; 48(3):799-801.
  6. Kim AS. Stroke risk prediction after transient ischaemic attack. Lancet Neurol. 2016 Nov; 15(12):1199-1200.
  7. Kim AS, Moffatt E, Ursell PC, Devinsky O, Olgin J, Tseng ZH. Sudden neurologic death masquerading as out-of-hospital sudden cardiac death. Neurology. 2016 Oct 18; 87(16):1669-1673.
  8. Kim AS, Easton JD, Johnston SC. Risk of Stroke after Transient Ischemic Attack or Minor Stroke. N Engl J Med. 2016 Jul 28; 375(4):386-7.
  9. Shamy MC, Pugliese M, Meisel K, Rodriguez R, Kim AS, Stahnisch FW, Smith EE. How Patient Demographics, Imaging, and Beliefs Influence Tissue-Type Plasminogen Activator Use: A Survey of North American Neurologists. Stroke. 2016 Aug; 47(8):2051-7.
  10. Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, Kim AS, Johnson JN, Bates D, King B, Case C, McGrogan M, Yankee EW, Schwartz NE. Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study. Stroke. 2016 Jul; 47(7):1817-24.
  11. Yuan K, Kim AS. When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy. Curr Treat Options Cardiovasc Med. 2016 Apr; 18(4):26.
  12. Ballard DW, Huang J, Vinson DR, Reed ME, Kim AS. In reply. Ann Emerg Med. 2016 Apr; 67(4):561-2.
  13. Feldman WB, Kim AS, Josephson SA, Lowenstein DH, Chiong W. Effect of waivers of consent on recruitment in acute stroke trials: A systematic review. Neurology. 2016 Apr 19; 86(16):1543-51.
  14. Kene MV, Ballard DW, Vinson DR, Rauchwerger AS, Iskin HR, Kim AS. Emergency Physician Attitudes, Preferences, and Risk Tolerance for Stroke as a Potential Cause of Dizziness Symptoms. West J Emerg Med. 2015 Sep; 16(5):768-76.
  15. Kim AS, Cahill E, Cheng NT. Global Stroke Belt: Geographic Variation in Stroke Burden Worldwide. Stroke. 2015 Dec; 46(12):3564-70.
  16. Ballard DW, Kim AS, Huang J, Park DK, Kene MV, Chettipally UK, Iskin HR, Hsu J, Vinson DR, Mark DG, Reed ME. Implementation of Computerized Physician Order Entry Is Associated With Increased Thrombolytic Administration for Emergency Department Patients With Acute Ischemic Stroke. Ann Emerg Med. 2015 Dec; 66(6):601-10.
  17. Coralic Z, Kim AS, Vinson DR. Prochlorperazine-Induced Hemidystonia Mimicking Acute Stroke. West J Emerg Med. 2015 Jul; 16(4):572-4.
  18. Cheng NT, Kim AS. Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset. Neurohospitalist. 2015 Jul; 5(3):101-9.
  19. Alexander MD, Rebhun JM, Hetts SW, Kim AS, Nelson J, Kim H, Amans MR, Settecase F, Dowd CF, Halbach VV, Higashida RT, Cooke DL. Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis. J Neurointerv Surg. 2016 May; 8(5):466-70.
  20. Choi JC, Hsia RY, Kim AS. Regional availability of mechanical embolectomy for acute ischemic stroke in California, 2009 to 2010. Stroke. 2015 Mar; 46(3):762-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.